A Study of JNJ-67953964 in Healthy Japanese Adult Male Participants

NCT04791332 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-67953964
DRUG: Placebo

Sponsor

Janssen Pharmaceutical K.K.